Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels by Bogenberger, James M & Laybourn, Paul J
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
Retrovirology
Open Access Research
Human T Lymphotropic Virus Type 1 protein Tax reduces histone 
levels
James M Bogenberger and Paul J Laybourn*
Address: Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado, USA
Email: James M Bogenberger - jimbog@simla.colostate.edu; Paul J Laybourn* - paul.laybourn@colostate.edu
* Corresponding author    
Abstract
Background: Human T-Lymphotropic Virus Type-1 (HTLV-1) is an oncogenic retrovirus that
causes adult T-cell leukemia/lymphoma (ATLL). The virally encoded Tax protein is thought to be
necessary and sufficient for T-cell leukemogenesis. Tax promotes inappropriate cellular
proliferation, represses multiple DNA repair mechanisms, deregulates cell cycle checkpoints, and
induces genomic instability. All of these Tax effects are thought to cooperate in the development
of ATLL.
Results: In this study, we demonstrate that histone protein levels are reduced in HTLV-1 infected
T-cell lines (HuT102, SLB-1 and C81) relative to uninfected T-cell lines (CEM, Jurkat and Molt4),
while the relative amount of DNA per haploid complement is unaffected. In addition, we show that
replication-dependent core and linker histone transcript levels are reduced in HTLV-1 infected T-
cell lines. Furthermore, we show that Tax expression in Jurkat cells is sufficient for reduction of
replication-dependent histone transcript levels.
Conclusion: These results demonstrate that Tax disrupts the proper regulation of replication-
dependent histone gene expression. Further, our findings suggest that HTLV-1 infection uncouples
replication-dependent histone gene expression and DNA replication, allowing the depletion of
histone proteins with cell division. Histone proteins are involved in the regulation of all metabolic
processes involving DNA including transcription, replication, repair and recombination. This study
provides a previously unidentified mechanism by which Tax may directly induce chromosomal
instability and deregulate gene expression through reduced histone levels.
Background
Human T-lymphotropic virus type 1 (HTLV-1) is a com-
plex retrovirus originally isolated in 1980 from a patient
with cutaneous T-cell lymphoma [1]. After the identifica-
tion of HTLV-1 as the first human retrovirus, it was dem-
onstrated to be associated with a malignancy of T
lymphocytes known as adult T-cell leukemia/lymphoma
(ATLL) [2-6]. ATLL is now known to be a direct result of
HTLV-1 infection [7]. HTLV-1 is also associated with non-
malignant, lymphocyte-mediated inflammatory diseases,
including the neurodegenerative disease tropical spastic
paraparesis/HTLV-I associated myelopathy (TSP/HAM)
[8-10].
The pathogenesis of HTLV-1 differs from that of other
known retroviruses. Unlike the acutely transforming ret-
roviruses, HTLV-1 does not encode an oncogene trans-
duced from a host genome [11]. Additionally, HTLV-1 can
Published: 31 January 2008
Retrovirology 2008, 5:9 doi:10.1186/1742-4690-5-9
Received: 1 November 2007
Accepted: 31 January 2008
This article is available from: http://www.retrovirology.com/content/5/1/9
© 2008 Bogenberger and Laybourn; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
Page 2 of 14
(page number not for citation purposes)
induce ATLL independently of the cis-acting effects of pro-
viral integration, distinguishing it from the slowly trans-
forming, cis-acting retroviruses [12]. Like other
retroviruses, the HTLV-1 genome consists of two long-ter-
minal repeats (LTRs) flanking the common retroviral
genes gag, pro, pol, and env [11]. HTLV-1 contains an addi-
tional genomic segment between the env gene and the 3'
LTR, called the pX region [13]. The pX region contains
four partially overlapping open reading frames (ORFs),
encoding several nonstructural or accessory viral gene
products required for viral replication and infectivity [14-
19]. ORF IV encodes the viral transcription factor Tax [13].
Tax is essential for replication of the HTLV-1 genome and
is required for HTLV-1 pathogenesis. Although there is no
known cellular homolog, Tax is considered to be an onco-
protein. Tax has been shown to be necessary and sufficient
to transform primary T-cells and form tumors in trans-
genic mice [6,20-24].
The oncogenic capacity of Tax resides in its ability to
induce inappropriate cell proliferation, inhibit DNA
repair pathways, deregulate cell cycle checkpoint controls,
and induce genomic instability. These effects of Tax on
cellular homeostasis are mediated both by Tax deregula-
tion of cellular gene expression and by direct Tax interac-
tions with multiple regulators of cellular homeostasis [25-
27]. It is thought that all of these effects of Tax function to
promote viral replication [28]. HTLV-1 infected cells pro-
duce virtually no cell-free infectious virus particles.
Rather, infection appears to be mediated by cell-to-cell
contact [29-31]. The ability of Tax to drive cell cycle pro-
gression and inactivate cell cycle checkpoints promotes
replication of the proviral genome, but consequently
results in an increased frequency of neoplasia in the host
cell.
In addition to Tax, the HTLV-1 genome encodes five other
accessory proteins, p12I, p30II, p13II, HBZ and Rex. Of
these proteins, p12I, p30II and p13II are not essential for
viral replication in vitro and Rex is not required for T-cell
immortalization [32]. However, experiments in animal
models using infectious viral clones suggest that these
other accessory proteins are important for productive
infection in vivo [33-35]. Accessory protein p12I localizes
to the endoplasmic reticulum and Golgi and appears to
promote cell survival and proliferation through increased
cytoplasmic Ca++ levels [36]. This protein may also partic-
ipate in immune response evasion through reduction of
MHC expression [37]. Similarly, p30II may function to
promote cell proliferation at the same time as viral latency
through effects on CBP/p300 function, as well as, Tax and
Rex mRNA translation [38-40]. Accessory protein p13II
localizes to the mitochondrial inner membrane and
affects K+ permeability and Ca++ uptake suggesting a func-
tion through Ca++ signaling, as well [41]. The HBZ open
reading frame is transcribed from the minus DNA strand
using a promoter in the 3'-LTR and is thought to produce
both a protein and an RNA product [42-44]. HBZ RNA
appears to promote T-cell proliferation while the protein
product suppresses viral transcriptional activation by Tax
[45,46]. Rex function is important for viral replication, as
it drives the transition to production of full-length
genomic RNA [47,48]. Rex is thought to recognize a
sequence in the viral RNA (Rex response element; RxRE),
repress splicing, and promote nuclear export [49]. Rex has
also been shown to be dispensable for virion production
in vitro, but to be essential in vivo [50].
Evidence from clinical studies suggests that fewer than 5%
of infected individuals develop ATLL and that manifesta-
tion of ATLL occurs after a long latent period between 20–
60 years [51]. These observations suggest that secondary
events are required in the progression from HTLV-1 infec-
tion to T-cell transformation and the development of
ATLL. Multi-step oncogenesis is thought to be driven by
reduced DNA repair capacity and/or genomic instability
[52].
Both ATLL cells and those immortalized by HTLV-1 infec-
tion and Tax expression in culture exhibit a broad spec-
trum of chromosomal abnormalities, including deletions,
duplications, translocations and anneuploidy [53,54].
Tax expression and DNA damage have been correlated in
studies demonstrating that Tax expression results in the
formation of micronuclei [55,56]. Tax expression has
been shown to induce gene amplification, as well [57].
Tax expression has been observed to cause an uncoupling
of DNA synthesis from cell division and result in the for-
mation of multinucleated giant cells exhibiting
decondensed, highly convoluted and polylobulated
nuclei [58]. This phenotype is similar to that of the large
lymphocytes with cleaved or cerebriform nuclei observed
at higher frequencies in HTLV-1 positive individuals [59].
The clastogenic effects of Tax have been correlated with
unstabilized double strand DNA breaks [60]. Currently,
there is no clear mechanism for how chromosomal abnor-
malities arise in HTLV-1 infected cells and there is no evi-
dence linking a specific chromosomal abnormality to the
development of ATLL.
Histones are critical components of chromatin and are
required for the proper packaging of genomic DNA within
the eukaryotic nucleus. The core histones assemble with
DNA into nucleosome core particles, the fundamental
units of chromatin. Arrays of nucleosome core particles
constitute a chromatin fiber, the primary level of chroma-
tin structure. The chromatin fiber is further compacted
through the formation of additional levels of higher order
chromatin structure. Linker histones are thought to mod-
ulate nucleosome dynamics and higher-order chromatinRetrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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structure formation. Ultimately, the chromatin fiber is
compacted by non-histone proteins forming metaphase
chromatids or chromosomes, the most compacted state of
genomic DNA. Histones and chromatin structure play a
central role in the regulation of all DNA metabolic proc-
esses, including transcription, repair, replication and
recombination [61].
In the present study we demonstrate that HTLV-1 infected
T-cell lines exhibit a reduction of replication-dependent
histone protein and transcript levels relative to uninfected
T-cell lines. However, we detect no concomitant decrease
in genomic DNA. Further, we show that Tax expression in
an uninfected T-cell line is sufficient to repress replication-
dependent histone transcript levels. These results provide
a previously unidentified mechanism through which Tax
may deregulate gene expression. Additionally, these
results provide a mechanism by which Tax may directly
induce genomic instability.
Results
Phenotypically, ATLL cells exhibit enlarged, polylobu-
lated nuclei as well as micronuclei [56,59]. In addition,
the viral transcription factor Tax is thought to deregulate
the expression of hundreds of cellular genes [62-65]. We
were interested in investigating the possibility that these
attributes result, in part, from defects in forming proper
chromatin structure. Since histones are critical to the for-
mation of chromatin structure, we hypothesized that
HTLV-1 infection and Tax perturb normal histone gene
expression.
Histone H3 and H1 levels are reduced in HTLV-1 infected 
T-cell lines
To quantify histone protein levels we sought to measure
histone protein and DNA content simultaneously using a
flow cytometry based assay. This assay has several advan-
tages over other methods of measuring cellular histone
protein levels. In normal cells, histone protein levels are
dependent on cellular DNA content. This fact has impor-
tant consequences for the measurement of histone pro-
tein levels in different cell lines. Differences in the amount
of DNA per haploid complement will result in concomi-
tant differences in histone protein levels during inter-
phase. Additionally, as cells replicate genomic DNA
during S-phase, histone protein levels will increase along
with the DNA content. Thus, simultaneous quantification
of histone protein and DNA content allowed us to nor-
malize histone protein levels to DNA content. The ability
to detect the slight increases in both histone protein and
DNA content as cells progress through S-phase attests to
the quantitative sensitivity of our assay.
Histone H3 and DNA content were measured simultane-
ously by flow cytometry. The antibody used (see Materials
and Methods) is directed against the H3 carboxyl-termi-
nus and recognizes modified forms of H3 and H3 vari-
ants. In addition, H3 forms the core heterotetramer of
nucleosomes, along with H4. It is important to note that
somatic cells, regardless of cell cycle phase, contain no sig-
nificant histone pools and levels of all four core histones
and total linker histone are finely balanced. It has been
estimated that even during S phase, the soluble histone
pool represents about 0.1% of the total histone in human
cells [66,67]. Therefore, the levels of H3 measured using
this antibody are indicative of the nucleosomal levels on
the chromosomes. During flow cytometry, the level of
anti-H3 antibody bound per cell was measured using an
Alexa 488-conjugated secondary antibody. Cells were also
stained with propidium iodide (PI) to determine genomic
DNA content. Unstained cells, as well as cells treated with
primary antibody only, secondary antibody only, PI only,
or primary and secondary antibody only were included as
controls in every experimental analysis to determine back-
ground fluoresence and in instrument calibration.
Mean histone H3 signal intensity was traced from G1
through G2/M and plotted against mean genomic DNA
content (Figure 1A). This was accomplished by defining a
narrow window on each DNA histogram so that the his-
tone H3 levels for the corresponding cell population
defined by the window could be determined at a particu-
lar DNA content level. Our results show that upon initia-
tion of DNA replication at the onset of S phase, cells
exhibit a near linear increase in both DNA and histone H3
content. As cells approach G2/M histone H3 immunoflu-
oresence was observed to plateau in all T-cell lines exam-
ined (both infected and uninfected), while PI fluorescence
(DNA content) continued to increase in a near linear fash-
ion. The plateau in H3 immunofluoresence observed may
be explained by a decrease in H3 antibody epitope acces-
sibility during chromosome condensation. Nevertheless,
the simultaneous measurement of histone levels and
DNA content using flow cytometry is clearly sensitive and
quantitative enough to accurately measure the slight
increases in both DNA and histone associated with
genome replication as cells progress through S phase of
the cell cycle. To display the histone H3 levels measured
for each of the cell lines examined, the average histone
H3:DNA ratios corresponding to G1, Mid-S and G2/M cell
populations were calculated for each cell line and
expressed relative to Jurkat (Figure 1B).
To summarize our results, histone H3 levels are not signif-
icantly different between each of the three uninfected T-
cell lines, Jurkat, CEM and Molt4. In clear contrast, H3
levels are reduced 20 to 40% in the HTLV-1 infected T-cell
lines, SLB-1, HuT102 and C81, relative to Jurkat cells. The
p-values associated with the measurement of histoneRetrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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H3:DNA ratios are shown in Table 1. The reduction in his-
tone H3 observed is consistent throughout the cell cycle.
Histone H1 protein levels were determined using the
same flow cytometry-based assay. Histone H1 levels are
plotted against genomic DNA content (Figure 1C) and
histone H1:DNA ratios are determined (Figure 1D). His-
tone H1 protein levels are not significantly different in the
two uninfected T-cell lines examined, Jurkat and Molt4.
However, histone H1 protein levels are reduced by 40% in
the two infected T-cell lines examined, C81 and HuT102
as compared to the uninfected T-cell lines, Molt4 and Jur-
kat. The p-values associated with the measurement of his-
tone H1:DNA ratios are shown in Table 2. The reduction
of histone H1 is also consistent throughout the cell cycle.
Histone H3 and H1 levels are reduced relative to genomic DNA content Figure 1
Histone H3 and H1 levels are reduced relative to genomic DNA content. Histone H3 and genomic DNA content 
were measured simultaneously in uninfected T-cell lines (CEM, Jurkat and Molt4) and HTLV-1 infected T-cell lines (SLB-1, 
HuT102 and C81) using flow cytometry. H3 levels were measured using a primary antibody directed against the C-terminal 
domain and an Alexa-488 labeled secondary antibody. DNA content was measured using propidium iodide. (A) Mean histone 
H3 immunofluorescent intensity was traced from G1 through G2/M by defining a narrow window on the DNA histogram and 
plotted against the genomic DNA content for the corresponding cell population defined by the window. (B) The average his-
tone H3:DNA ratios of three experiments during G1, Mid-S and G2/M are shown for HTLV-1 infected and uninfected T-cell 
lines (see Table 1 for p-values) (C) Histone H1 and genomic DNA content were measured simultaneously in uninfected T-cell 
lines (Jurkat and Molt4) and in HTLV-1 infected T-cell lines (C81 and HuT102) using flow cytometry. H1 levels were measured 
using a primary antibody directed against the C-terminal domain and an Alexa-488 labeled secondary antibody. DNA content 
was measured using propidium iodide. Mean histone H1 immunofluorescent intensity was traced from G1 through G2/M by 
defining a narrow window on the DNA histogram and plotted against the genomic DNA content for the corresponding cell 
population defined by the window. (D) The average histone H1:DNA ratios during G1, Mid-S and G2/M are shown for HTLV-
1 infected and uninfected T-cell lines (see Table 2 for p-values).Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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Having unequivocally determined that histone protein
levels are reduced in HTLV-1 infected T-cell lines, we pro-
ceeded to determine if this was a result of reduced histone
message levels.
Replication-dependent histone transcript levels are 
reduced in HTLV-1 infected T-cell lines
The replication-dependent histones are expressed from
multiple gene copies. While their amino acid sequences
are highly conserved they are divergent enough in their
DNA sequences as to require a separate primer set for the
measurement of transcript from each of the gene copies by
real-time PCR. Therefore, Northern blot analysis was
employed allowing the measurement of total transcript
levels for each replication-dependent histone type. His-
tone transcript levels in each cell line were normalized
against EF1α. Northern blot analyses revealed a reduction
of histone transcripts from all of the replication-depend-
ent histone genes (Figure 2A). Quantification of the
Northern blot results revealed a reduction in core and
linker histone transcript levels ranging from two to five-
fold, depending on the histone, in HTLV-1 infected T-cell
lines (HUT102, SLB-1 and C81) as compared to Jurkat T-
cells (Figure 2B). On average, histone transcripts are
reduced by 66%, 61% and 50% in SLB-1, HuT102 and
C81 cells respectively. Histone transcript levels in the
other uninfected T-cell lines examined, Molt4 and CEM,
were either not significantly different from or slightly
higher than Jurkat. These results indicate that HTLV-1
infection is reducing histone protein levels through an
effect on histone transcript levels.
All linker histone isoform transcript levels are reduced in 
HTLV-1 infected T-cell lines
We used reverse-transcription and real-time PCR to deter-
mine the transcript levels of each of the somatic linker his-
tone isoforms. Real-time PCR quantification of linker
histone cDNAs generated from an uninfected T-cell line
(Jurkat) and from an HTLV-1 infected T-cell line (SLB-1)
reveals a significant reduction of somatic linker histone
transcripts in the HTLV-1 infected T-cell line when com-
pared to the uninfected T-cell line (Figure 2C). H1S-1,
H1S-2, H1S-3, and H1S-4 transcripts are 6, 14, 9 and 4-fold
lower in SLB-1 cells, respectively, relative to Jurkat T-cells.
These results indicate that HTLV-1 infection is reducing
histone protein levels through an effect on histone tran-
script levels.
Tax expression alone reduces histone transcript levels in 
an uninfected T-cell line
The HTLV-1 provirus encodes several viral proteins, but
only the Tax protein is known to be oncogenic. To deter-
mine if Tax alone is sufficient to repress histone gene
expression, we transiently transfected an uninfected T-cell
line (Jurkat) with a Tax expression vector (pSG-Tax) or
empty vector (pUC-19). Both sets of cells were cotrans-
fected with a vector encoding a surface molecule (trun-
cated mouse MHC Class I) to allow selection of
transfectants by their retention on magnetic beads conju-
gated to antibody recognizing this unique surface marker.
Real-time PCR was used to evaluate all of the somatic
linker histone mRNAs and representative family members
of the core histone genes in Tax expressing and pUC-19
transfected Jurkat cells. Tax expression was verified by
both western blot and real-time PCR (not shown).
Both core and linker histone mRNAs were reduced in Tax
expressing Jurkat cells as compared to pUC-19 transfected
Jurkat cells (Figure 3A). Core and linker histone mRNA
levels are reduced in the range of three- to five-fold, simi-
lar to the reduction observed in HTLV-1 infected T-cell
lines. Replication-dependent histones are only tran-
scribed in S phase of the cell cycle. To eliminate the possi-
bility that Tax expressing cells reduce replication-
dependent histone transcript levels by reducing the pro-
portion of cells in S phase, we determined cell cycle distri-
butions of pSG-Tax and pUC-19 transfected Jurkat cells.
pSG-Tax and pUC-19 transfected Jurkat cells used for RNA
extraction were subjected to cell cycle analysis. The per-
centage of cells in S phase of Tax expressing Jurkat cell
populations was 31%, while that of pUC-19 transfected
Jurkat cells was 36% (Figure 3B). The reduction of histone
mRNAs observed in Tax expressing Jurkat cells due to the
lower proportion of cells in S phase is no more than 14%
(31/36). Therefore, Tax effects on cell cycle distribution
do not account for the remaining 52 to 66% reduction in
Table 1: P-values for data in Figure 1B. Note: Jurkat values have 
been set to 1.0.
H3:DNA G1 Mid-S G2/M
CEM 1.7 × 10-1 2.2 × 10-1 1.5 × 10-1
Molt4 1.6 × 10-1 4.2 × 10-1 2.6 × 10-1
SLB-1 3.0 × 10-3 1.5 × 10-2 1.1 × 10-2
HuT102 2.2 × 10-2 9.4 × 10-5 6.4 × 10-3
C81 2.6 × 10-2 6.0 × 10-2 3.3 × 10-2
Table 2: P-values for data in Figure 1D. Note: Jurkat values have 
been set to 1.0.
H1:DNA G1 Mid-S G2/M
Molt4 3.5 × 10-1 3.9 × 10-1 2.5 × 10-1
C81 1.1 × 10-1 8.0 × 10-2 6.0 × 10-2
HuT102 5.0 × 10-2 1.0 × 10-2 2.0 × 10-2Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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Replication-dependent core and linker histone transcripts are reduced in HTLV-1 infected T-cell lines Figure 2
Replication-dependent core and linker histone transcripts are reduced in HTLV-1 infected T-cell lines. (A) 
Core and linker histone transcript levels were measured in uninfected T-cell lines (CEM, Jurkat and Molt4) and HTLV-1 
infected T-cell lines (SLB-1, HuT102 and C81) by northern blotting. (B) Graphical representation of northern blot quantifica-
tion. Histone transcript signals were normalized to EF1α transcript signals. Values for all T-cell lines are expressed relative to 
Jurkat cells. P-values associated with northern blot measurements of total histone transcripts for each cell line were: CEM – 2.3 
× 10-3, Molt4 – 1.1 × 10-4, SLB-1 – 5.8 × 10-12, HuT102 – 2.9 × 10-8, C81 – 2.8 × 10-6 (C) Linker histone isoform transcripts are 
reduced in HTLV-1 infected T-cell lines. Somatic linker histone isoform transcript levels were measured in an uninfected T-cell 
line (Jurkat) and an HTLV-1 infected T-cell line (SLB-1), using reverse-transcription and real-time PCR. Linker histone tran-
script levels were normalized to EF1α transcript levels and values were expressed relative to transcript levels in Jurkat cells 
[110].Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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histone transcript levels observed in these Tax transfection
studies.
Discussion
In this study we have shown that histone protein levels are
reduced 20 to 40% in HTLV-1 infected T-cell lines as com-
pared to uninfected T-cell lines and that this reduction
correlates with decreased histone transcript levels. Addi-
tionally, we have shown that Tax alone is sufficient to
decrease histone transcript levels. Replication-dependent
histones are expressed only in S phase, so it was formally
possible that the reduction in histone transcript levels
observed after Tax expression in an uninfected T-cell line
was the result of a significant decrease in the proportion
of the cell population in S phase. We have ruled out this
possibility by analyzing cell cycle distributions of Tax
expressing T-cells as compared to empty vector transfected
T-cells (Figure 3B). Further, by measuring histone H3 lev-
els and DNA content per cell simultaneously through flow
cytometry we have demonstrated that the reduced histone
levels observed in HTLV-1 infected T-cell lines do not
occur through a reduction in the amount of genomic DNA
in these cells. Rather, our results indicate that Tax deregu-
lates histone production and this occurs, at least in part,
through a decrease in histone gene transcripts resulting in
reduced histone proteins assembled into nucleosomes on
the genomic DNA. Furthermore, our data indicate that
HTLV-1 infection can uncouple replication-dependent
histone gene expression from DNA synthesis. It is impor-
tant to point out that we cannot exclude cooperative
Tax expression is sufficient for reduction of replication-dependent histone transcript levels Figure 3
Tax expression is sufficient for reduction of replication-dependent histone transcript levels. (A) Histone tran-
script levels were measured in pSG-Tax transfected Jurkat cells and empty vector transfected Jurkat cells using reverse-tran-
scription and real-time PCR. P-values associated with the measurement of histone transcripts in pUC-19 vs pSG-Tax 
transfected Jurkat cells were: H2A – 3.7 × 10-6, H2B – 3.4 × 10-5, H3 – 5.6 × 10-3, H4 – 3.5 × 10-2, average H1 – 1.1 × 10-2. (B) 
DNA content analysis reveals similar cell cycle distributions for pSG-Tax transfected and empty vector transfected Jurkat cells.Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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effects from one or more of the other accessory HTLV-1
proteins in either the reduction of histone levels or the
uncoupling of histone expression from DNA replication.
However, Tax is sufficient to reduce histone mRNAs.
Replication-dependent histone genes
In normal somatic cells, expression of the majority of his-
tone genes is tightly coupled to the rate of DNA replica-
tion during S phase of the cell cycle. Thus, they are termed
replication-dependent histone genes. Under normal cir-
cumstances inhibition of histone synthesis results in DNA
replication arrest. Conversely, blocking DNA replication
results in a coordinate inhibition of histone expression
[68]. The coordination of histone expression and DNA
synthesis is critical in the maintenance of chromosomal
integrity [69]. Histone chaperones and chromatin assem-
bly factors normally cooperate in the deposition of his-
tones onto nascent DNA as it emerges from the replication
fork [70]. The down-regulation of histone gene expression
in response to decreased rates of DNA synthesis prevents
the accumulation of excess histones, which has been
shown to be highly cytotoxic and to severely compromise
the transmission of chromosomal information [71]. Since
there is no significant pool of non-nucleosomal histones,
chromatin assembly at the replication fork is dependent
on de novo histone expression.
Mammalian cell division requires the synthesis of 108 his-
tone proteins during the brief S phase. In order to meet
these demands, cells contain multiple copies of the repli-
cation-dependent histone genes. Genomic sequence anal-
ysis has revealed 59 replication-dependent core histone
genes and 6 replication-dependent linker histone genes,
clustered at 4 different chromosomal loci in human cells
[72]. The expression of all the replication-dependent his-
tone genes is coordinately regulated during S phase. This
coordinate regulation is mediated through both transcrip-
tional and post-transcriptional mechanisms. It is not
known how each of these different transcriptional and
post-transcriptional mechanisms of histone gene regula-
tion are coupled to the rate of DNA synthesis in prolifer-
ating cells.
Replication-dependent histone gene transcriptional 
regulation
The rate of transcription of all the replication-dependent
histone genes increases three- to five-fold as cells enter S
phase. Studies have shown that proper cell cycle-depend-
ent transcriptional regulation of each histone subtype
involves unique cis-regulatory elements and unique tran-
scription factors for each histone subtype. It is not known
how these different DNA-binding transcription factors are
coordinated to activate transcription of all the replication-
dependent histone genes in response to cell cycle signal-
ing [73,74]. Recently, non DNA-binding proteins have
been identified that may be involved in coordinating his-
tone gene transcription. Hir1p and Hir2p are cell cycle
regulators thought to be responsible for transcriptional
co-repression of histone gene expression in Saccharomyces
cerevisiae [75]. HIRA is the mammalian homolog of these
yeast proteins and may regulate histone gene expression
in mammalian cells. HIRA has been shown to display his-
tone chaperone function independent of DNA synthesis
[76]. It has also been shown to be phosphorylated by cyc-
lin E/cdk2 during S phase and is thought to be inhibited
by this phosphorylation. The ectopic expression of HIRA
is known to result in S phase arrest and reduced histone
transcript levels, suggesting a negative function for HIRA
in replication-dependent histone gene expression outside
of S phase [77].
NPAT is another mammalian protein thought to function
in the coordinate expression of replication-dependent his-
tone genes [78,79]. NPAT has also been shown to be an in
vivo substrate of cyclin E/cdk2. Phosphorylation of NPAT
correlates with the colocalization of NPAT to histone
processing bodies. Inhibition of NPAT gene expression
impedes cell cycle progression and decreases histone gene
expression in mammalian cells [80]. Thus, NPAT is
thought to participate in the up-regulation of replication-
dependent histone gene expression during S phase.
Replication-dependent histone gene post-transcriptional 
regulation
Post-transcriptional mechanisms of histone gene expres-
sion are responsible for an additional eight- to ten-fold
increase in mRNA levels as cells enter S phase [81,82]. The
replication-dependent histones do not contain introns
and are not polyadenylated. Instead, they all contain a
very similar 3' stem-loop structure bound by a conserved
protein in mammals, stem-loop binding protein (SLBP)
[83,84]. SLBP mediates the only RNA processing event
required for production of mature histone mRNAs, a 3'-
endonucleolytic cleavage [85]. In addition, SLBP binding
regulates the half-life and translational efficiency of his-
tone mRNAs [86-88].
Potential mechanisms of Tax deregulation of histone 
expression
As the promoters for the genes encoding the four replica-
tion-dependent histones have been shown to utilize
unique cis-acting elements bound by different sequence-
specific trans-acting factors during S-phase induced
expression, Tax mediated repression of histone expression
is likely to occur through an effect on one or more of the
coordinating regulators of histone expression, HIRA,
NPAT, or SLBP. The difference in reduction of histone pro-
tein levels (20 to 40%) and histone transcript levels (50 to
80%) suggests some compensation may occur through
increased mRNA stability, translation efficiency or proteinRetrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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stability. In addition, results from this study suggest that
HTLV-1 infection is able to uncouple the interdependence
of histone gene expression and DNA synthesis. There is lit-
tle known about the mechanism coupling histone synthe-
sis and DNA replication. One candidate for this function
is the histone chaperone Asf1 (Asf1a and Asf1b in mam-
malian cells), which has been shown to regulate histone
levels during replicational stress [89]. Tax may provide a
useful probe to investigate this coupling mechanism, as
well as the mechanism of coordinate histone gene regula-
tion in general.
Potential effects of histone level reduction
We find HTLV-1 infected cells with ~30% reductions in
histone levels form apparently normal metaphase chro-
mosomes, at least at the resolution of light microscopy
(not shown). This indicates the reduction has more subtle
effects. At the same time, we find that lower histone levels
are not compensated for by merely increasing the nucleo-
somal repeat length to evenly distribute the remaining
nucleosomes (not shown). Thus, one must assume there
is a corresponding increase in non-nucleosomal DNA.
Chromatin structure plays a central role in the regulation
of all DNA metabolic processes including transcription,
replication, repair and recombination [61]. Post-transla-
tional modifications on the histone tails and histone var-
iants are thought to be critical in the determination of
cellular identity [90,91]. As every cell in a multi-cellular
organism contains the same genomic information, cell
differentiation and specialization require that distinct
transcriptional programs are established and maintained
[92,93]. Post-translational modifications on the histone
tails are thought to impart cellular memory through epi-
genetic control of the genome [93]. Thus, every unique
cell type is thought to exhibit a unique set of chromosome
"marks", governing the genome-wide transcriptome and
ultimately cellular identity. We suggest that a reduction of
histone levels in HTLV-1 infected T-cells will result in loss
of epigenetic information and may contribute to Tax
deregulation of cellular gene expression leading to cancer.
We expect reduced histone levels to have similar effects as
those observed with loss of imprinting (LOI) through
DNA hypomethylation. These effects include aberrant
chromosome rearrangements, deregulation of cellular
gene expression and activation of latent viral genomes
[94-100]. Reduction of histone levels could provide a
means for HTLV-1 transcriptional reactivation after meth-
ylation of the 5' LTR in cultured ATLL cells [101].
Defects in chromatin assembly have been shown to
impair all known pathways of double-strand break repair
and activate S phase arrest [102,103]. Furthermore, partial
depletion of histone H4 has been shown to increase
homologous recombination-mediated genetic instability
[104].
Chromatin structure, nucleosome remodeling and the
epigenetic information encoded on the histone tails are
known to participate in double-strand DNA break repair
[105-108]. Defects in nucleosome assembly have been
shown to interfere with the repair of double-strand DNA
breaks [102]. We suggest that a Tax-mediated decrease in
histone levels will result in an increase in the incidence of
double-strand DNA breaks. The ability of Tax to increase
the frequency of double-strand DNA break formation is
consistent with its ability to increase the propensity for
micronuclei formation [55,56]. Double-strand DNA
breaks are potent inducers of genome instability as they
are repaired by the error-prone process of non-homolo-
gous end joining, when a sister chromatid is not available
for more efficient recombination-mediated repair [109].
Decreased histone levels may represent a previously
unknown means for Tax induction of DNA damage.
Conclusion
While the transforming capability of Tax has been demon-
strated, the mechanisms of transformation by Tax are not
completely understood. We suggest Tax repression of rep-
lication-dependent histone gene expression will result in
reactivation of viral gene expression, deregulation of cel-
lular gene expression and genomic instability. All of these
effects may contribute to the development of adult T-cell
leukemia/lymphoma. To our knowledge, this is the first
example of a reduction of histone levels correlating with
viral infection and cancer development.
Methods
Cell lines and cell culture
(C81, CEM, HuT102, Jurkat, Molt-4, and SLB-1) T-cell
lines were cultured in Iscove's Modified Dulbecco's Media
(IMDM; Sigma-Aldrich) supplemented with 10% fetal
bovine serum, 50,000 units/liter each streptomycin/peni-
cillin and 2 mM L-glutamine. All T-cell lines were cultured
at 37°C in the presence of 5% CO2.
RNA extraction and cDNA synthesis
RNA was extracted from asynchronous cells (107) using
Trizol (Invitrogen) in accordance with the manufacturer's
protocol. In order to reduce genomic contamination, RNA
samples were treated with 20 units of RNase-free DNase I
(Roche) at room temperature for 30 minutes before heat
inactivating the DNase I at 65°C for 10 minutes. cDNA
was synthesized with the iScript cDNA synthesis kit (Bio-
Rad) according to manufacturer's protocol using a pro-
grammable thermal cycler.Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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Real-time PCR
Relative real-time PCR was performed using iQ SYBR
Green Supermix (Bio-Rad) on an iCycler (Bio-Rad) and
data expressed according to the Michael Pfaffl method,
using EF1α as an internal control for normalization [110].
A five-point standard curve was constructed by serial
diluting target DNA to evaluate PCR efficiency for every
primer pair in every experiment. Reactions were per-
formed in triplicate for every experiment. Real-time PCR
amplicons were electrophoresed on 1.5% agarose gels to
verify the specificity of each primer pair and melt curves
were analyzed for every experiment to ensure that ampli-
fication products were primer pair specific. The following
primer sequences were used for real-time PCR:
H2A Fwd AGCTCAACAAGCTTCTGGGCAA;
H2A Rev TTGTGGTGGCTCTCGGTCTTCTT;
H2B Fwd TGCGCCCAAGAAGGGTTCTAAA;
H2B Rev ACGAAGGAGTTCATGATGCCCA;
H3 Fwd TGCTCATCCGCAAACTGCCATT; H3 Rev AGT-
GACACGCTTGGCGTGAATA; H4 Fwd ACCGTAAAGTAC
TGCGCGACAA; H4 Rev TTCTCCAGGAACACCTTCAGC
A; H1S-1 Fwd CCTGTAAAGAAGAAGGCGGCCAAA;
H1S-1 Rev CAGAGAAACTCCGCTACGCTCTTT;
H1S-2 Fwd CCCAGTATCTGAGCTTATCACCAAGG;
H1S-2 Rev TTTCTTAAGCGCGGCCAGAGAAAC;
H1S-3 Fwd CCCGGCTAAGAAGAAGGCAACTAA;
H1S-3 Rev GAAAGGCCATTGCGCTCCTTAGAA;
H1S-4 Fwd CCGGTGTCCGAGCTCATTACTAAA;
H1S-4 Rev GCTTTCTTGAGAGCGGCCAAAGAT;
EF1α Fwd GCCTCTCCAGGATGTCTACAAA;
EF1α Rev GTTTGAGAACACCAGTCTCCACTC;
Tax Fwd TTCTACCCGAAGACTGTTTGCCCA;
Tax Rev TGTCCAAATAAGGCCTGGAGTGGT.
Histone content relative to DNA content determination by 
flow cytometry
Asynchronous cells (5 × 106) from log phase culture were
pelleted and suspended in ice-cold phosphate buffered
saline (PBS). Cell suspensions were transferred to ice-cold
1% formaldehyde (methanol-free) in PBS and chilled on
ice for 15 minutes to fix cells. Cells were washed with ice-
cold PBS and transferred to ice-cold 70% ethanol and let
stand at -20°C for 2 hours to permeablize cells. Cells were
washed with PBS and incubated in 1% BSA-PBS contain-
ing 5 µg primary antibody (ab1791 rabbit polyclonal to
Histone H3, AbCam or mouse monoclonal antibody
directed against histone H1 product # V7013, Biomeda),
overnight at 4°C while rotating. Cells were then washed
with 1% BSA-PBS and incubated in a 1% BSA-PBS solu-
tion containing 5 µg of Alexa Fluor 488 goat anti-rabbit
second antibody (product # A11008, Molecular Probes)
for Histone H3 analysis or Alexa Fluor 488 goat anti-
mouse second antibody (product # A11029, Molecular
Probess) for Histone H1 analysis, for 1 hour at room tem-
perature. Cells were washed with 1% BSA-PBS and incu-
bated in PBS containing 25 ug/mL propidium iodide
(Sigma) and 40 Kunitz U/mL RNase A (Sigma, certified
DNase-free) for 30 minutes at room temperature. Cells
were analyzed on a MoFlo (Dako Cytomation) flow
cytometer/cell sorter with laser excitation at 488 nm with
110 mW. Data was interpreted using Summit software,
version 4.0 (Dako Cytomation).
Northern blots
Total RNA (10 µg) was resolved on 1% agarose/6.6% for-
maldehyde gels. Samples were transferred to a nylon
membrane and probed with histone and EF1α probes
simultaneously. PhosphorImager screens were scanned
on a STORM (Molecular Probes). Histone signals were
quantified with ImageQuant software version 5.1 (Molec-
ular Dynamics) and normalized to EF1α signals. Probes
were generated using a random primed DNA labeling kit
(Roche). The DNA templates used for the generation of
32P-radiolabeled probes for histone and EF1α transcripts
were prepared by PCR from Jurkat genomic DNA using
the following primers:
H1 Fwd AAGGAGCGCAATGGCCTTTCTTTG;
H1 Rev GCCTTCTTGGCCTTTGCAGCTTTA;
H2A Fwd TTCAGTTTCCCGTAGGCCGAGT, H2A Rev GA
AGCTTGTTGAGCTCCTCATCGT;
H2B Fwd AAGAAGGATGGCAAGAAGCGCAAG;
H2B Rev ACTTGGAGCTGGTGTACTTGGTGA;
H3 Fwd ATCGCTATCGGCCTGGTACAGT;
H3 Rev AGCTGGATGTCCTTGGGCATGATA;
H4 Fwd ATGTCAGGACGCGGCAAAGGAGGTAA;Retrovirology 2008, 5:9 http://www.retrovirology.com/content/5/1/9
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H4 Rev GATCACGTTCTCCAGGAACACCTTCA;
EF1α Fwd TCATTGGACACGTAGATTCGGGCA;
EF1α Rev TTCACACCCAGTGTGTAAGCCAGA.
The DNA template used for the generation of 32P-radiola-
beled probes for Tax transcripts was prepared by PCR from
pSG-Tax plasmid DNA using the following primers:
Tax Fwd TTCCCAGGGTTTGGACAGAGTCTT;
Tax Rev GCGTGCCATCGGTAAATGTCCAAA.
Co-transfection and magnetic selection of transfectants
Jurkat cells were co-transfected with pSG-Tax/pMACs Kk
or pUC-19/pMACs Kk at 20 ug total DNA (3.5 molar
excess of pMACs Kk) per 107 cells by electroporation in 0.4
cm cuvettes using Genepulse (Bio-Rad). Transfected cells
were enriched 24 hours following electroporation using
the pMACS Kk magnetic selection system (Miltenyi Biotec)
according to the manufacturer's protocol. Enriched cell
populations were cultured for an additional 24 hours
prior to harvesting cells for RNA extraction and DNA con-
tent analysis.
DNA content analysis
Asynchronous cells (106) from log phase culture were
fixed with 70% ethanol and low molecular weight DNA
was extracted with a 4 mM sodium citrate/192 mM
sodium phosphate wash. Fixed cells were stained with 50
ug/mL propidium iodide in PBS containing 730 Kunitz U/
mL RNase A for 20 minutes at room temperature. Data
was collected on an EPICS flow cytometer (Beckman
Coulter) and cell cycle distributions were calculated using
Multicycle (Phoenix Flow Systems).
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